Loading...
Loading...
Chiquita Brands
International, Inc.
("Chiquita") today is mailing a letter to its
shareholders that highlights key parts of a presentation the Company filed
with the U.S. Securities and Exchange Commission ("SEC") in which Chiquita
sets the record straight regarding the flawed and misleading statements made
by the Cutrale Group and the Safra Group ("Cutrale / Safra") in connection
with Chiquita's proposed combination with Fyffes plc (ESM: FFY ID: AIM: FFY
LN) ("Fyffes"). The presentation is available on the investor relations
section of Chiquita's website: www.chiquita.com.
The full text of the letter is below:
September 2, 2014
Dear Fellow Chiquita Shareholder,
Approximately two weeks ago, Chiquita's Board of Directors unanimously
determined that the unsolicited, contingent proposal from Cutrale / Safra to
acquire Chiquita for $13.00 per share is inadequate and reiterated its
recommendation in favor of the transaction with Fyffes. Since then, Cutrale /
Safra has had ample opportunity to submit a revised proposal, but has chosen
not to do so. Instead, Cutrale / Safra has dug in at $13.00 per share and made
multiple inaccurate and misleading public statements attempting to discredit
Chiquita's Board and management team, as well as the highly compelling
combination with Fyffes.
We are taking this opportunity to set the record straight and, once again,
point out that the Cutrale / Safra $13.00 proposal is an inferior alternative
to ChiquitaFyffes and that the proposal itself is opportunistic, at a low
premium and based off an artificial low in Chiquita's stock price.
CUTRALE / SAFRA'S MISLEADING STATEMENTS AND FLAWED CALCULATIONS FAIL TO MAKE
THE CASE THAT THEIR CONTINGENT $13 PER SHARE PROPOSAL IS ADEQUATE AND IN THE
BEST INTERESTS OF CHIQUITA AND ITS SHAREHOLDERS
X Cutrale / Safra Grossly Understates the Value of the ChiquitaFyffes
Transaction
* Reality: Cutrale / Safra selectively compares its contingent proposal of
$13.00 per share to an outdated illustrative analysis, performed in
February 2014 and described in Chiquita's proxy statement of August 6,
2014, of the implied present value of the future share price of
ChiquitaFyffes. That analysis assumed $40 million of synergies – not $60
million – and outdated Fyffes forecasts that were approximately $10
million lower than Fyffes' latest guidance. The Cutrale / Safra contingent
proposal is inadequate, especially when compared to the updated analysis.
The updated analysis, when performed on a consistent basis to reflect the
updated estimated incremental synergies and earnings and calculated to
December 2014 (the assumed completion date of a transaction with Cutrale /
Safra), indicates implied present value of future share prices, but
without giving effect to any control premium, in the range of $13.09 –
14.69 per share and discounted cash flow value of $14.32 – 16.90 per
share^1.
X Cutrale / Safra Grossly Overstates the Transaction Multiple Offered to
Chiquita Shareholders
* Reality: The Cutrale / Safra proposal is a low multiple by any measure.
Cutrale / Safra's use of Chiquita's reported adjusted EBITDA^2 for the
last 12 months ended June 30, 2014, is an inappropriate reference point
against which to compare the multiple in the Cutrale / Safra proposal.
This is because Chiquita's last twelve months EBITDA is not indicative of
its future performance as it does not give Chiquita credit for, amongst
other things:
* Significant performance improvements already implemented;
* Elimination of one-time or special costs or charges;
* $10 million impact from Chiquita's Midwest salad plant
consolidation, and
* $18 million attributable to weather related costs in the first
quarter of 2014.
* The turnaround currently underway in Chiquita's salads business; and
* Future efficiencies
* For example, the $14-16 million shipping efficiencies announced
by Chiquita on August 27, 2014
Chiquita is clearly in the midst of a turnaround, as evidenced by the increase
in its EBITDA by 69% in 2013 compared to 2012 and an estimated increase of
approximately 19% in 2014 compared to 2013^3. The implied multiple provided by
Cutrale / Safra based on Chiquita's stand-alone LTM as of June 30, 2014,
adjusted for special charges is 9.4x, Chiquita's stand-alone estimated 2014
EBITDA is only 8.6x, and against ChiquitaFyffes estimated pro forma combined
2014 EBITDA, including run rate synergies, is 6.9x, not 11.8x.^4 Chiquita
shareholders are not being asked to sell Chiquita as a stand-alone business.
They are being asked to sell the value achievable in a Chiquita/Fyffes
transaction. Accordingly, the Cutrale / Safra proposal is misleading,
misrepresented and inadequate.
X Cutrale / Safra Grossly Overstates the "Premium" Offered to Chiquita
Shareholders
* Reality: The Cutrale / Safra proposal is opportunistic and based off an
artificial low period in Chiquita's historical stock price. By stating
selectively that it represents a 29.2% premium Cutrale / Safra ignores
that its proposal represents a:
* 4.2% discount to the 52-week high point (before announcement of the
combination with Fyffes) in Chiquita's closing stock price of $13.57,
realized on September 11, 2013;
* 2.8% premium to Chiquita's stock price of $12.64^5, the high point at
which the stock traded post-announcement of the Fyffes transaction
and pre-announcement of first quarter earnings; and
* 19.8% premium to Chiquita's stock price of $10.85 on June 30, 2014.
It is also based on flawed calculations:
* In its calculations, Cutrale / Safra incorrectly discounts future values
to today rather than to its stated year-end target for closing the
transaction. This error alone has an impact to valuation of about 50
cents per share.
* Cutrale / Safra assumes unreasonably low growth rates for the
ChiquitaFyffes business. As mentioned above, Chiquita is in a turnaround
and has forecast approximately 19% EBITDA growth for this year.^6 In
addition, Fyffes generated an EBITDA CAGR of more than 16% between 2008
– 2013.
* Cutrale / Safra also applies low LTM EBITDA multiples relative to
historical and current trading levels to calculate share prices.
When using accurate numbers and assumptions and appropriately discounting the
values shown in Chiquita's previous presentation to year-end 2014, the
resulting values are meaningfully in excess of the $13 per share proposal.
Cutrale / Safra's analysis is incorrect, based on flawed assumptions and does
not reflect a change of control premium for the company. Accurate calculations
demonstrate that Cutrale / Safra's proposal is a purchase of the company at a
discount to the present value for ChiquitaFyffes.
X Cutrale / Safra Grossly Misrepresents Fyffes Business and Performance
Track-Record
* Reality: Since 2008, Fyffes has grown its EBITDA faster than any of its
fresh produce peers.^7 In addition, Fyffes is far less volatile than
Chiquita or others in the industry as evidenced by the fact that 74% of
Fyffes European sales are contracted.^8
Fyffes also has significant land under management and contributes
approximately 10,000 managed hectares to the merger, in comparison to
Chiquita's 16,000 hectares.^9 Since 2007, Fyffes has spent $108 million to
acquire the farms that it currently operates.^10
The Fyffes merger increases geographic, sourcing and fruit diversification and
reduces exposure to any single market.
X Cutrale / Safra Grossly Misrepresents Synergies in the ChiquitaFyffes
Transaction
* Reality: Chiquita and Fyffes have identified an additional $20 million of
synergies for a total of at least $60 million in annualized cost synergies
by the end of 2016^11. These synergy estimates have been carefully
prepared and, in accordance with the requirements of the Irish Takeover
Rules, documented and third party reviewed. When the transaction was
initially reviewed, Chiquita's Board considered synergy sensitivities that
exceeded the $40 million estimate as publicly announced with announcement
of the transaction, and since then, integration planning / synergy teams
have validated the additional $20 million and are continuing their work.
X Cutrale / Safra Grossly Misrepresents Entering Negotiations as a
"Risk-Free" option
* Reality: Contrary to Cutrale / Safra's assertions, there is considerable
risk to Chiquita shareholders should the Company engage in discussions
with Cutrale / Safra. In fact, there are many contingencies attached to
the Cutrale / Safra proposal and any delay in closing the Fyffes
transaction will result in a deferral to Chiquita shareholders of the
anticipated benefits of the transaction. Also, there is risk that Fyffes
may walk away from the transaction, if its shareholders vote against the
transaction as a result of our engaging in discussions regarding the
Cutrale / Safra proposal. This is a risk not worth taking given the terms
of the existing proposal.
THERE IS NO "RISKLESS OPTION" -- THE CHOICE IS CLEAR FOR CHIQUITA SHAREHOLDERS
The Chiquita Board is aware of its fiduciary duties and, in consultation with
its financial and legal advisors, carefully reviewed Cutrale / Safra's
proposal and unanimously determined that $13.00 per share does not constitute
a Chiquita Superior Proposal and is an inadequate price at which to negotiate
a sale of Chiquita. Cutrale / Safra have had the opportunity to submit a
revised proposal over the past two weeks and have chosen not to do so. There
is no reason to delay the Fyffes deal, especially as any delay will cost
Chiquita shareholders in terms of the present value of delayed synergy
implementation and risks the Fyffes transaction ultimately not being
consummated. The choice is clear:
1. Vote "FOR" a better company, with greater potential to create value for
shareholders. ChiquitaFyffes post-merger is a better and a more valuable
business than Chiquita as a stand-alone company without the proposed
merger. By voting "FOR" ChiquitaFyffes, shareholders have the opportunity
to realize future appreciation of their share value as a result of the
benefits of the combination, while maintaining the option of entertaining
future offers for the combined company, at the right price; or
2. Vote for no deal. Cutrale / Safra has had the opportunity to propose a
transaction that fairly reflects the future value of Chiquita, but has not
put forward a compelling proposal. Chiquita will not engage at an
inadequate price.
MAXIMIZE THE VALUE OF YOUR INVESTMENT IN CHIQUITA
VOTE "FOR" THE PROPOSED TRANSACTION WITH FYFFES
The Chiquita Board unanimously recommends that you vote your shares "FOR" the
proposed transaction with Fyffes: by signing, dating and returning the
Company's proxy card at your earliest convenience. The Chiquita Board also
unanimously recommends that you vote your shares "FOR" the other proposals
being presented by Chiquita, including the proposal on adjournment, so that
your Board, acting in your interests, can determine the terms of any
adjournment. In accordance with applicable rules, the designated proxies will
use their discretionary authority to vote on any other matters properly
presented at the meeting, based on the then applicable facts and
circumstances. Internet and telephone voting options are also available and
easy to follow instructions may be found in your proxy. Your vote is
important.The method by which you vote does not limit your right to vote in
person at the special meeting. We urge you not to return or sign any GOLD
proxy card sent to you by Cutrale / Safra.
In addition to Alliance Advisors, LLC, whose contact information is contained
in Chiquita's Proxy Statement, shareholders may also contact MacKenzie
Partners Inc. with any questions or for assistance in submitting their proxy.
Contact information for MacKenzie Partners is set forth below.
___________________________________
MacKenzie
Partners, Inc.
105 Madison Avenue
New York, NY 10016
(212) 929-5500 (call collect)
Or
TOLL-FREE (800) 322-2885
___________________________________
On behalf of your Board of Directors, we thank you for your continued support.
Sincerely,
Edward F. Lonergan
President and Chief Executive Officer
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in